Root Financial Partners
ORMP icon

Root Financial Partners’s Oramed Pharmaceuticals ORMP Stock Holding History

Root Financial Partners’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$98 Buy
+21
New +$95 ﹤0.01% 3651

Other funds holding ORMP

Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
SCM
Sage Capital Management Stockton, New Jersey $263M AUM 22.29% 1-Year Est. Return
Redwood Family Wealth
Redwood Family Wealth Addison, Texas $113M AUM 24.54% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Root Financial Partners's ORMP Position: Q3 2026 in Review

Root Financial Partners opened a new position in Oramed Pharmaceuticals (ORMP) in Q3 2026: 21 shares worth $98. The stake represents ﹤0.01% of the portfolio and ranks #3651 among its holdings.

8 funds tracked by Wall St. Rank hold ORMP as of Q3 2026.

  • Root Financial Partners held 21 shares of Oramed Pharmaceuticals worth $98 as of Q3 2026.
  • Oramed Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3651 holding.
  • 8 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.